Title |
Behavioral Effects of Acute Systemic Low-Dose Clozapine in Wild-Type Rats: Implications for the Use of DREADDs in Behavioral Neuroscience
|
---|---|
Published in |
Frontiers in Behavioral Neuroscience, August 2018
|
DOI | 10.3389/fnbeh.2018.00173 |
Pubmed ID | |
Authors |
Ann-Kathrin Ilg, Thomas Enkel, Dusan Bartsch, Florian Bähner |
Abstract |
Designer receptors exclusively activated by designer drugs (DREADDs) are popular tools used to manipulate the activity of defined groups of neurons. Recent work has shown that DREADD effects in the brain are most likely not mediated by the proposed ligand clozapine-N-oxide (CNO) but its metabolite clozapine (CLOZ). However, it is not known whether low doses of CLOZ required to activate DREADDs already have DREADD-independent effects on behavior as described for higher CLOZ doses used in previous preclinical studies. To close this gap, we compared effects of acute systemic (i.p.) CLOZ treatment vs. vehicle (VEH) in a wide range of behavioral tests in male wild-type rats. We found that CLOZ doses as low as 0.05-0.1 mg/kg significantly affected locomotion, anxiety and cognitive flexibility but had no effect on working memory or social interaction. These results highlight the need for careful controls in future chemogenetic experiments and show that previous results in studies lacking CNO/CLOZ controls may require critical re-evaluation. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 8 | 36% |
United Kingdom | 2 | 9% |
Thailand | 1 | 5% |
Japan | 1 | 5% |
Switzerland | 1 | 5% |
Mexico | 1 | 5% |
Canada | 1 | 5% |
Unknown | 7 | 32% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 14 | 64% |
Scientists | 7 | 32% |
Practitioners (doctors, other healthcare professionals) | 1 | 5% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 117 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 24 | 21% |
Researcher | 19 | 16% |
Student > Master | 19 | 16% |
Student > Bachelor | 16 | 14% |
Student > Doctoral Student | 6 | 5% |
Other | 9 | 8% |
Unknown | 24 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 54 | 46% |
Agricultural and Biological Sciences | 13 | 11% |
Biochemistry, Genetics and Molecular Biology | 8 | 7% |
Psychology | 6 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Other | 8 | 7% |
Unknown | 25 | 21% |